BioAge Labs, Inc. (BIOA)

7.05 -0.16 (-2.22%) USD  |  NASDAQ  |  Sep 25, 16:00
7.05 0.00 (0.00%) After-Hours: 19:59
More

BioAge Labs Research and Development Expense (Annual) : 73.97M for Dec. 31, 2025

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for BIOA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Research and Development Expense (Annual) Data

View and export this data back to 2022. Start Trial.
Date Value
December 31, 2025 73.97M
December 31, 2024 59.04M
Date Value
December 31, 2023 33.89M
December 31, 2022 30.52M

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Eli Lilly & Co. 13.34B
Pfizer Inc. 10.25B
Oramed Pharmaceuticals, Inc. 6.381M
Liquidia Corp. 38.45M
Neumora Therapeutics, Inc. 176.06M